GleamWall
中文EN

TRLV Trulieve Cannabis Corp.

Medicinal Chemicals & Botanical Products · NYSE · SEC CIK 1754195 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-9.1%
TTM net income YoY-218.5%
TTM EPS YoY-245.5%
Revenue 3-yr CAGR-1.8%
Net income 3-yr CAGR—

Margins

Gross margin60.6%
Operating margin-25.6%
Net margin-41.3%
FCF margin16.2%
EBITDA margin-16.1%

Returns

ROE-45.2%
ROA-17.7%
ROIC (approx.)-24.8%
Asset turnover0.43x

Leverage & solvency

Liabilities / assets63.6%
Debt / equity0.25x
Current ratio5.52x
Interest coverage-5.25x

Cash quality & payout

Operating cash flow / net income-0.54x
Accruals ratio-27.2%
Payout ratio—
Capex / revenue6.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY2025*2025-12-31FY2024*2024-12-31
Income statement
Revenue$1.18B$1.19B
Cost of revenue$470.01M$470.75M
Gross profit$711.17M$715.75M
SG&A expense$445.21M$510.45M
Operating income$143.50M$97.78M
Interest expense$63.45M$62.19M
Pretax income$91.47M$42.71M
Income tax$208.11M$197.59M
Net income-$116.38M-$155.10M
EBITDA$261.13M$210.59M
EPS (basic)-0.58-0.79
EPS (diluted)-0.58-0.79
Weighted avg. shares (diluted)191.32M189.99M
Balance sheet
Cash & equivalents$255.53M$238.80M
Short-term investments$0$60.39M
Receivables$10.50M$8.29M
Inventory$242.30M$231.37M
Current assets$562.72M$604.56M
PP&E, net$670.44M$716.05M
Goodwill$483.90M$483.90M
Intangibles$798.37M$859.48M
Total assets$2.70B$2.87B
Current liabilities$126.94M$138.49M
Long-term debt$136.74M$364.84M
Total debt$136.74M$364.84M
Total liabilities$1.55B$1.62B
Shareholders' equity$1.16B$1.26B
Net debt-$118.79M$126.03M
Shares outstanding192.31M191.01M
Cash flow statement
Operating cash flow$272.82M$271.48M
Capital expenditure$44.19M$122.60M
Free cash flow$228.63M$148.88M
Investing cash flow$13.50M-$206.62M
Financing cash flow-$270.50M-$33.44M
Depreciation & amortization$117.63M$112.81M
Stock-based compensation$20.47M$20.20M

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.